The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Patients’ Perceptions Of Generic Medications
Open accessAbstract
Insurers and policymakers encourage the use of generic drugs to reduce costs, but generics remain underused. We conducted a national survey of commercially insured adults to evaluate their perceptions about generic drugs. Patients agreed that generics are less expensive and a better value than brand-name drugs, and are just as safe. However, although 56 percent reported that Americans should use more generics, only 37.6 percent prefer to take generics. We discuss perceptions about communicating with practitioners about generics, generic substitution, and policymakers' role in influencing generic use. These findings underscore the challenge that providers, insurers, and policymakers face in stimulating the cost-effective use of medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple imputation in health‐are databases: An overview and some applications
Rubin, D. B., & Schenker, N. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100410 · Cited by 1,550
Commercial Features of Placebo and Therapeutic Efficacy
(2008) · JAMA · doi:10.1001/jama.299.9.1016 · Cited by 383
Shrank, W. H., Hoang, T., Ettner, S. L., Glassman, P. A., Nair, K., DeLapp, D., Dirstine, J., Avorn, J., & Asch, S. M. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.3.332 · Cited by 343
Self-citationHaas, J. S., Phillips, K. A., Gerstenberger, E. P., & Seger, A. C. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-11-200506070-00006 · Cited by 271
Economic Implications of Evidence-Based Prescribing for Hypertension: Can Better Care Cost Less?
Fischer, M. A., & Avorn, J. (2004) · JAMA · doi:10.1001/jama.291.15.1850 · Cited by 183
Self-citationConsumer Perceptions of Risk and Required Cost Savings for Generic Prescription Drugs
Ganther, J. M., & Kreling, D. H. (2000) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31086-5 · Cited by 126
Patient, Physician, Pharmacy, and Pharmacy Benefit Design Factors Related to Generic Medication Use
Shrank, W. H., Stedman, M. R., Ettner, S. L., DeLapp, D., Dirstine, J., Brookhart, M. A., Fischer, M. A., Avorn, J., & Asch, S. M. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0284-3 · Cited by 64
Self-citationThe effect of pharmacy benefit design on patient-physician communication about costs
Shrank, W. H., Fox, S., Kirk, A. M., et al. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00402.x · Cited by 50
Self-citationImpact of Alternative Interventions on Changes in Generic Dispensing Rates
O’Malley, A. J., Frank, R. G., Kaddis, P. A. A., Rothenberg, B. M., & McNeil, B. J. (2006) · Health Services Research · doi:10.1111/j.1475-6773.2006.00579.x · Cited by 50
Federman, A. D., Halm, E. A., & Siu, A. L. (2007) · Medical Care · doi:10.1097/01.mlr.0000250293.24939.2e · Cited by 40
Cited by
Kesselheim, A. S. (2008) · JAMA · doi:10.1001/jama.2008.758 · Cited by 431
Leong, D. P., Joseph, P. G., McKee, M., Anand, S. S., Teo, K. K., Schwalm, J.-D., & Yusuf, S. (2017) · Circulation Research · doi:10.1161/circresaha.117.311849 · Cited by 419
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
WOUTERS, O. J., KANAVOS, P. G., & McKEE, M. (2017) · The Milbank Quarterly · doi:10.1111/1468-0009.12279 · Cited by 287
Qian, J., & Tanni, K. A. (2021) · Endocrine · doi:10.1007/s12020-021-02833-8 · Cited by 2
Metadata
- Authors
- Shrank, W. H., Cox, E. R., Fischer, M. A., Mehta, J., & Choudhry, N. K.
- Venue
- Health Affairs
- Publisher
- Health Affairs Publishing, LLC
- Published
- 2009-03
- Volume
- 28
- Issue
- 2
- Pages
- 546-556
- ISSN
- 0278-2715 (ISSN-L)
- 1544-5208
- OpenAlex
- W2057124956
- Cited by
- 255
- References
- 12
- FWCI
- 34.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patients’ Perceptions Of Generic Medications. https://app.cochat.ai/papers/10.1377/hlthaff.28.2.546
- The paper
- Shrank, W. H., Cox, E. R., Fischer, M. A., Mehta, J., & Choudhry, N. K. (2009). Patients’ Perceptions Of Generic Medications. Health Affairs. https://doi.org/10.1377/hlthaff.28.2.546
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.